Cancer patients’ pain can be helped by psychosocial interventions, say researchers
Up to one-third of cancer patients experience moderate to severe pain.
Up to one-third of cancer patients experience moderate to severe pain.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
Foreward by Dr Sanjay Popat (pictured). The 14th Annual Scientific Meeting of the IASLC has now closed. Held in Amsterdam at the beginning of July 2011, the annual… read more.
Nephrotoxicity as the Primary Driver of Failure – Fact or Fiction? – Dr Philip Halloran, Alberta Applied Genomics Center, Alberta, Canada. The calcineurin inhibitors (CNIs), ciclosporin and tacrolimus,… read more.
Advertisment